DNA Supramolecular Hydrogel-Enabled Sustained Delivery of Metformin for Relieving Osteoarthritis
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.2c20496 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Chao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China. Hauptthemen laut MEDLINE: Metformin, Osteoarthritis, Cartilage, Articular. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Guangzhou Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Osteoarthritis (OA) is a musculoskeletal disorder affecting ∼500 million people worldwide. Metformin (MET), as an oral hypoglycemic drug approved by the Food and Drug Administration, has displayed promising potential for treating OA. Nonetheless, in the articular cavity, MET suffers from rapid clearance and cannot circumvent the severe inflammatory environment, greatly confining the therapeutic efficacy. Herein, DNA supramolecular hydrogel (DSH) has been utilized as a sustained drug delivery vehicle for MET to treat OA, which dramatically prolonged the retention time of MET in the articular cavity from 3 to 14 days and simultaneously exerted a greater anti-inflammatory effect. Our delivery platform, termed MET@DSH, better protects cartilage than single-agent MET. Additionally, the corresponding molecular mechanisms underlying the therapeutic effects were also analyzed. We anticipate this DNA supramolecular hydrogel-enabled sustained drug delivery and anti-inflammatory strategy will reshape the current landscape of OA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China.
- Department of Rheumatology and Immunology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China.
- Centre of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China.
- College of Biological and Geographical Sciences, Yili Normal University, Yining, Xingjiang 835000, China.
- Clinical Research Centre, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510180, China.
- Department of Nuclear Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
ORCID-Profile: Jian He
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Guangzhou Basic and Applied Basic Research Foundation
Zitieren
APA
Zhang, C., Huang, H., Chen, J., Zuo, T., Ou, Q., Ruan, G., He, J., & Ding, C. (2023). DNA Supramolecular Hydrogel-Enabled Sustained Delivery of Metformin for Relieving Osteoarthritis. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.2c20496
Vancouver
Zhang C, Huang H, Chen J, Zuo T, Ou Q, Ruan G, et al. DNA Supramolecular Hydrogel-Enabled Sustained Delivery of Metformin for Relieving Osteoarthritis. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.2c20496
BibTeX
@article{Zhang2023,
author = {Zhang, Chao and Huang, Hong and Chen, Jianmao and Zuo, Tingting and Ou, Qianhua and Ruan, Guangfeng and He, Jian and Ding, Changhai},
title = {DNA Supramolecular Hydrogel-Enabled Sustained Delivery of Metformin for Relieving Osteoarthritis},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.2c20496}
}
EUVIMED